Dehydroepiandrosterone | CAS:53-43-0
            
            Dehydroepiandrosterone
            - Name:Dehydroepiandrosterone
 - CAS:53-43-0
 - Synonyms:DHEA; Prasterone; Androstenolone; Dehydroisoandrosterone; trans-Dehydroandrosterone; Hydroxyandrost-5-en-17-one
 - Molecular Formula:C19H28O2
 - Molecular Weight:288.43
 - EINESC:200-175-5
 
Description
Properties
| Melting point | 146-151 ºC | 
|---|---|
| Specific optical rotation | 12 º (c=2, ethanol 96% 25 & | 
Safety
| SDS/MSDS | S24/25 | 
|---|
SDS
| Source | SDS/MSDS Samples | 
|---|---|
| 没有数据 | 没有数据 | 
Synthetic Route
                Articles
                Peer-Reviewed Papers
                
                                        Spiroborate esters in the borane-mediated asymmetric synthesis of pyridyl and related heterocyclic alcohols.Viatcheslav Stepanenko et al.Tetrahedron, asymmetry, 18(23), 2738-2745 (2007-11-26)
                                        A pharmacotherapeutic approach to the regulation of hyperinsulinemia and obesity.J Triscari et al.International journal of obesity, 11 Suppl 3, 43-51 (1987-01-01)
                                        Selective inhibition of thromboxane synthesis in glycerol-induced acute renal failure.A J Watson et al.American journal of kidney diseases : the official journal of the National Kidney Foundation, 8(1), 26-30 (1986-07-01)
                                        Attenuation of the development of hypertension in spontaneously hypertensive rats by the thromboxane synthetase inhibitor, 4'-(imidazol-1-yl) acetophenone.H D Uderman et al.Prostaglandins, 24(2), 237-244 (1982-08-01)
                                        Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative.W D Watkins et al.Prostaglandins, 23(3), 273-285 (1982-03-01)
                                        Suppression of urinary albumin excretion in diabetic rats by 4'(imidazol-1-yl) acetophenone, a selective inhibitor of thromboxane synthesis.P A Craven et al.The Journal of laboratory and clinical medicine, 116(4), 469-478 (1990-10-01)
                                    
            Remarks
                
            Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
        
Related Products
Related News
Question
    Hot Tags
    Inquiry
Fill in related informations ;please!
- Please fill in product name !
 - CAS
 - Please fill in your company information correctly!
 - Please fill in liaison information correctly!
 - Please fill in your telephone number correctly!
 - Please fill in your email correctly!
 - Please describe the problem of products!